Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Angus

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Clinical Science (London, England : 1979)|April 18, 2009
Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated ratJohn S Lubel, Chandana B Herath, Jorge Tchongue, et al.
Journal of Hepatology|May 29, 2007
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosisChandana B Herath, Fiona J Warner, John S Lubel, et al.
World Journal of Gastroenterology|September 28, 2016
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver diseaseChristopher Leung, Chandana B Herath, Zhiyuan Jia, et al.
Transplantation|April 16, 2014
A novel biomarker of immune function and initial experience in a transplant populationSiddharth Sood, Diana Cundall, Lijia Yu, et al.
Journal of Gastroenterology and Hepatology|November 22, 2015
Additive impact of pre-liver transplant metabolic factors on survival post-liver transplantLeon A Adams, Oscar Arauz, Peter W Angus, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 31, 2019
Management of Patients With Erythropoietic Protoporphyria-Related Progressive Liver DiseaseZaid S Ardalan, Sujievvan Chandran, Abhinav Vasudevan, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesisDarrell H G Crawford, Linda M Fletcher, Stefan G Hubscher, et al.
World Journal of Hepatology|August 8, 2019
Epidemiology and outcomes of acute liver failure in AustraliaPenelope Hey, Timothy P Hanrahan, Marie Sinclair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 16, 2009
Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantationDaniel L Worthley, Douglas F Johnson, Damon P Eisen, et al.
Gastroenterology|January 18, 2012
Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis CTom W Chu, Rohit Kulkarni, Edward J Gane, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Clinical Science (London, England : 1979)|April 18, 2009
Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated ratJohn S Lubel, Chandana B Herath, Jorge Tchongue, et al.
Journal of Hepatology|May 29, 2007
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosisChandana B Herath, Fiona J Warner, John S Lubel, et al.
World Journal of Gastroenterology|September 28, 2016
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver diseaseChristopher Leung, Chandana B Herath, Zhiyuan Jia, et al.
Transplantation|April 16, 2014
A novel biomarker of immune function and initial experience in a transplant populationSiddharth Sood, Diana Cundall, Lijia Yu, et al.
Journal of Gastroenterology and Hepatology|November 22, 2015
Additive impact of pre-liver transplant metabolic factors on survival post-liver transplantLeon A Adams, Oscar Arauz, Peter W Angus, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 31, 2019
Management of Patients With Erythropoietic Protoporphyria-Related Progressive Liver DiseaseZaid S Ardalan, Sujievvan Chandran, Abhinav Vasudevan, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesisDarrell H G Crawford, Linda M Fletcher, Stefan G Hubscher, et al.
World Journal of Hepatology|August 8, 2019
Epidemiology and outcomes of acute liver failure in AustraliaPenelope Hey, Timothy P Hanrahan, Marie Sinclair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 16, 2009
Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantationDaniel L Worthley, Douglas F Johnson, Damon P Eisen, et al.
Gastroenterology|January 18, 2012
Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis CTom W Chu, Rohit Kulkarni, Edward J Gane, et al.
Pageof 12